End-of-day quote
New Zealand S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
11.1
NZD
|
-0.63%
|
|
+0.36%
|
+8.29%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,993
|
2,839
|
3,130
|
2,050
|
2,397
|
2,611
|
-
|
-
|
Enterprise Value (EV)
1 |
2,579
|
3,511
|
3,877
|
3,085
|
2,397
|
4,230
|
4,409
|
4,526
|
P/E ratio
|
11.5
x
|
12.4
x
|
5.78
x
|
7.61
x
|
5.48
x
|
12.2
x
|
11.3
x
|
10.4
x
|
Yield
|
1.58%
|
1.04%
|
1.35%
|
2.52%
|
-
|
2.16%
|
2.33%
|
2.52%
|
Capitalization / Revenue
|
12.9
x
|
16.5
x
|
15.2
x
|
8.59
x
|
8.81
x
|
8.08
x
|
7.03
x
|
6.15
x
|
EV / Revenue
|
16.8
x
|
20.4
x
|
18.9
x
|
12.9
x
|
8.81
x
|
13.1
x
|
11.9
x
|
10.7
x
|
EV / EBITDA
|
19.9
x
|
29.3
x
|
23.5
x
|
15.3
x
|
10.3
x
|
17
x
|
16.1
x
|
14.6
x
|
EV / FCF
|
-32,761,493
x
|
-
|
43,076,273
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.78
x
|
2.12
x
|
1.63
x
|
0.93
x
|
-
|
0.88
x
|
0.8
x
|
0.73
x
|
Nbr of stocks (in thousands)
|
223,904
|
226,246
|
228,812
|
231,645
|
233,855
|
235,250
|
-
|
-
|
Reference price
2 |
8.900
|
12.55
|
13.68
|
8.850
|
10.25
|
11.10
|
11.10
|
11.10
|
Announcement Date
|
2/24/20
|
2/22/21
|
2/23/22
|
2/23/23
|
2/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
153.9
|
172.4
|
205.3
|
238.7
|
272.2
|
323.3
|
371.3
|
424.8
|
EBITDA
1 |
129.4
|
119.9
|
164.7
|
202
|
233.6
|
248.2
|
273.1
|
310.6
|
EBIT
1 |
121.6
|
111.8
|
153.2
|
188.4
|
217.8
|
231.2
|
256.7
|
293.3
|
Operating Margin
|
78.98%
|
64.84%
|
74.59%
|
78.92%
|
80.01%
|
71.53%
|
69.14%
|
69.04%
|
Earnings before Tax (EBT)
|
173.6
|
221.7
|
543.6
|
265.1
|
-
|
-
|
-
|
-
|
Net income
1 |
175.3
|
230.8
|
543.7
|
269.1
|
436.3
|
281.8
|
302.1
|
340.9
|
Net margin
|
113.85%
|
133.84%
|
264.75%
|
112.72%
|
160.29%
|
87.19%
|
81.36%
|
80.23%
|
EPS
2 |
0.7752
|
1.012
|
2.369
|
1.164
|
1.871
|
0.9130
|
0.9805
|
1.063
|
Free Cash Flow
|
-78.72
|
-
|
90.01
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-51.13%
|
-
|
43.83%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
54.64%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
16.56%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1410
|
0.1300
|
0.1850
|
0.2230
|
-
|
0.2400
|
0.2591
|
0.2800
|
Announcement Date
|
2/24/20
|
2/22/21
|
2/23/22
|
2/23/23
|
2/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 S1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
133.1
|
Net margin
|
-
|
EPS
2 |
0.5730
|
Dividend per Share
|
-
|
Announcement Date
|
8/22/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
586
|
671
|
747
|
1,035
|
-
|
1,619
|
1,797
|
1,915
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.528
x
|
5.599
x
|
4.535
x
|
5.125
x
|
-
|
6.523
x
|
6.581
x
|
6.165
x
|
Free Cash Flow
|
-78.7
|
-
|
90
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
10.1%
|
7.91%
|
8.61%
|
8.33%
|
-
|
7.24%
|
7.1%
|
7.36%
|
ROA (Net income/ Total Assets)
|
3.48%
|
2.72%
|
3.2%
|
3.19%
|
-
|
2.84%
|
2.72%
|
2.78%
|
Assets
1 |
5,038
|
8,488
|
16,981
|
8,448
|
-
|
9,931
|
11,114
|
12,283
|
Book Value Per Share
2 |
4.990
|
5.920
|
8.390
|
9.470
|
-
|
12.60
|
13.80
|
15.20
|
Cash Flow per Share
2 |
1.050
|
-1.160
|
-2.590
|
-1.450
|
-
|
0.9200
|
1.020
|
1.150
|
Capex
1 |
317
|
237
|
293
|
395
|
-
|
613
|
622
|
636
|
Capex / Sales
|
205.66%
|
137.71%
|
142.88%
|
165.4%
|
-
|
189.51%
|
167.51%
|
149.66%
|
Announcement Date
|
2/24/20
|
2/22/21
|
2/23/22
|
2/23/23
|
2/25/24
|
-
|
-
|
-
|
Last Close Price
11.1
NZD Average target price
13.14
NZD Spread / Average Target +18.40% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.29% | 1.55B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -3.97% | 11.66B | | -1.42% | 11.72B | | -31.75% | 11.77B |
Other Healthcare Facilities & Services
|